Extracellular matrix-derived gels and related methods
View Patent ↗Provided are methods for preparing gelled, solubilized extracellular matrix (ECM) compositions useful as cell growth scaffolds. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the gelled, solubilized ECM is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and/or attachment of the device to a patient.
1. A method of preparing an extracellular matrix-derived gel comprising: (a) solubilizing decellularized extracellular matrix (ECM) derived from cardiac tissue by digestion with an acid protease in an acidic solution to produce digested cardiac ECM; and (b) raising the pH of the digested cardiac ECM to a pH between 7.2 and 7.8 to produce a neutralized digest solution, and (c) gelling the neutralized digest solution at a temperature greater than 25° C.
2. The method of claim 1 , wherein the ECM is not dialyzed or subjected to a cross-linking process prior to the gelling step (c).
3. The method of claim 1 , wherein the ECM is intact ECM.
4. The method of claim 1 , wherein the neutralized digest solution is maintained at or below 25° C. before the gelling step (c).
5. The method of claim 1 , wherein the protease is pepsin, trypsin or a combination thereof.
6. The method of claim 1 , wherein in the step of raising the pH of the digested cardiac ECM (b), a base or an isotonic buffer is added to raise the pH of the digested cardiac ECM.
7. The method of claim 6 , wherein the base or isotonic buffer is NaOH or phosphate buffered saline.
8. The method of claim 1 , wherein the pH is raised to 7.4 in the step of raising the pH of the digested cardiac ECM (b).
9. The method of claim 1 , wherein the digest solution is gelled at 30° C. or higher.
10. The method of claim 1 , wherein the digest solution is gelled at 37° C.
11. The method of claim 1 , wherein the gel is molded during the gelling step (c).
12. The method of claim 1 , further comprising integrating one or more of a cell, a drug, a cytokine and a growth factor into the gel prior to or after gelling step (c).
13. The method of claim 12 , in which the one or more of a cell, a drug, a cytokine and a growth factor is selected from the group consisting of an interferon, an interleukin, a chemokine, a monokine, a hormone, an angiogenic factor, and an antibiotic.
14. The method of claim 12 , comprising seeding the gel with cells prior to or after gelling step (c).
15. The method of claim 1 , further comprising coating a matrix of a biocompatible scaffold with the neutralized digest solution and gelling the matrix.
16. The method of claim 1 , further comprising dispersing the neutralized digest solution in an inorganic matrix.
17. The method of claim 16 , wherein the inorganic matrix comprises a metal.
18. The method of claim 16 , wherein the inorganic matrix comprises titanium.